Toxicogenomics and systems toxicology: aims and prospects

Michael D Waters1, Jennifer M Fostel

  • 1National Center for Toxicogenomics, National Institute of Environmental Health Sciences, PO Box 12233, MD F1-05, 111 Alexander Drive, Research Triangle Park, North Carolina 27709-2233, USA. waters2@niehs.nih.gov

Nature Reviews. Genetics
|December 2, 2004
PubMed

Insights

Toxicogenomics uses molecular profiling to understand how toxicants cause disease by studying gene-environment interactions. This evolving field of systems toxicology aims to predict toxic effects across species.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Environmental Health

Background:

  • Toxicogenomics integrates molecular profiling (transcript, protein, metabolite) with conventional toxicology.
  • It investigates gene-environment interactions in disease causation.
  • Understanding molecular expression patterns reveals toxicant mechanisms.

Purpose of the Study:

  • To highlight the evolution of toxicology towards a systems toxicology approach.
  • To address challenges in discriminating the molecular basis of toxicity.
  • To enable prediction of toxicant modes-of-action across species.

Main Methods:

  • Transcript, protein, and metabolite profiling.
  • Conventional toxicology methods.
  • Analysis of molecular expression patterns.

Main Results:

  • Identified how specific exposures alter molecular expression to cause disease.
  • Revealed mechanisms of action for several toxicants.
  • Highlighted challenges in discerning the molecular basis of toxicity.

Conclusions:

  • Toxicology is advancing to systems toxicology, enabling comprehensive understanding of toxicological interactions.
  • Systems toxicology facilitates prediction of toxicant effects in different species based on known responses.
  • This approach enhances our ability to manage environmental stress and disease causation.

Related Concept Videos

Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...